ICONIC LABS PLC LS-,00001 Logo
GB00BD060S65
A2APNF
ICON.L

ICONIC LABS PLC LS-,00001

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • Iconic Labs converts debenture into 458,716 ordinary shares

    Iconic Labs has received a conversion notice dated 1 June under which 458,716 ordinary shares will be issued at a conversion price of £0.0109. The nominal amount of the issue is £5,000. The company has applied for admission of the new shares to trading on the Main Market of the London Stock Exchange, expected from 8 June. After the issue the issued share capital will rise to 16,039,907 ordinary shares, which is also the total number of voting rights. » More on de.investing.com

Financials

In the last quarter, ICONIC LABS PLC LS-,00001 had revenue of €0 and net profit of -€323.92k
(EUR) June 2026
YoY
Revenue 0 -
Gross profit 0 -
Net profit -323.92k -
EBITDA -278.16k -

Fundamentals

Metric Value
Market capitalization
€305.01k
Number of shares
18.42m
52-week high/low
€0.0596 - €0.0127
Dividends No
Beta
0.99
P/E ratio
-0.37
PEG ratio
-0.01
P/B ratio
-0.05
P/S ratio
0.00

Company profile

Iconic Labs Plc provides consulting and agency services. The company offers advisory services to clients on their businesses; and delivers campaigns, as well as provides creative services to its clients. Its activities include monthly insights, content creation and distribution, post campaign analysis, and combining with online media brands. The company was formerly known as WideCells Group PLC and changed its name to Iconic Labs Plc in July 2019. Iconic Labs Plc was founded in 2012 and is based in London, the United Kingdom.

Name
ICONIC LABS PLC LS-,00001
CEO
John Forbes Farquharson
Headquarters London, gl
United Kingdom
Website
IPO
27/07/2016
Employees 3

Ticker symbols

Exchange Symbol
London Stock Exchange
ICON.L
Frankfurt
W0G.F
London
ICON.L
🍪

Parqet  uses cookies. Learn more